Header Logo

Connection

Theodore Pincus to Humans

Back to Details
This is a "connection" page, showing publications Theodore Pincus has written about Humans.
Theodore Pincus
Connection Strength
3.310
Humans
  1. HAQ and DAS28 for clinical trials over months and MDHAQ, RheuMetric and psycho-socio-economic measures for long-term observations over years? Rheumatology (Oxford). 2022 10 06; 61(10):3884-3886.
    View in: PubMed
    Score: 0.048
  2. Further Simplified Clinimetry Using a Multidimensional Health Assessment Questionnaire. J Rheumatol. 2023 03; 50(3):460.
    View in: PubMed
    Score: 0.048
  3. Should Quantitative Measures and Management of Rheumatoid Arthritis Include More Than Control of Inflammatory Activity? J Rheumatol. 2022 Mar; 49(3):336-338.
    View in: PubMed
    Score: 0.044
  4. Comment on: 'It can't be zero!' Difficulties in completing patient global assessment in rheumatoid arthritis: a mixed methods study. Rheumatology (Oxford). 2021 01 05; 60(1):e28-e29.
    View in: PubMed
    Score: 0.042
  5. Multidimensional Health Assessment Questionnaire as an Effective Tool to Screen for Depression in Routine Rheumatology Care. Arthritis Care Res (Hoboken). 2021 01; 73(1):120-129.
    View in: PubMed
    Score: 0.042
  6. Long-term Glucocorticoid Use in Rheumatoid Arthritis. J Rheumatol. 2021 08; 48(8):1342.
    View in: PubMed
    Score: 0.041
  7. Patient questionnaires in osteoarthritis: what patients teach doctors about their osteoarthritis on a multidimensional health assessment questionnaire (MDHAQ) in clinical trials and clinical care. Clin Exp Rheumatol. 2019 Sep-Oct; 37 Suppl 120(5):100-111.
    View in: PubMed
    Score: 0.039
  8. Low socioeconomic status and patient questionnaires in osteoarthritis: challenges to a "biomedical model" and value of a complementary "biopsychosocial model". Clin Exp Rheumatol. 2019 Sep-Oct; 37 Suppl 120(5):18-23.
    View in: PubMed
    Score: 0.039
  9. Osteoarthritis is as severe as rheumatoid arthritis: evidence over 40 years according to the same measure in each disease. Clin Exp Rheumatol. 2019 Sep-Oct; 37 Suppl 120(5):7-17.
    View in: PubMed
    Score: 0.039
  10. Fibromyalgia Assessment Screening Tool: Clues to Fibromyalgia on a Multidimensional Health Assessment Questionnaire for Routine Care. J Rheumatol. 2020 05 01; 47(5):761-769.
    View in: PubMed
    Score: 0.038
  11. Disease Burden in Osteoarthritis Is Similar to That of Rheumatoid Arthritis at Initial Rheumatology Visit and Significantly Greater Six Months Later. Arthritis Rheumatol. 2019 08; 71(8):1276-1284.
    View in: PubMed
    Score: 0.038
  12. Diagnosis of Fibromyalgia: Disagreement Between Fibromyalgia Criteria and Clinician-Based Fibromyalgia Diagnosis in a University Clinic. Arthritis Care Res (Hoboken). 2019 03; 71(3):343-351.
    View in: PubMed
    Score: 0.037
  13. Minimal Clinically Important Improvement of Routine Assessment of Patient Index Data 3 in Rheumatoid Arthritis. J Rheumatol. 2019 01; 46(1):27-30.
    View in: PubMed
    Score: 0.036
  14. Update on imaging in rheumatic diseases. Clin Exp Rheumatol. 2018 Sep-Oct; 36 Suppl 114(5):2.
    View in: PubMed
    Score: 0.036
  15. Assessment of pain and other patient symptoms in routine clinical care as quantitative, standardised, "scientific" data. Clin Exp Rheumatol. 2017 Sep-Oct; 35 Suppl 107(5):13-20.
    View in: PubMed
    Score: 0.034
  16. Pain and other self-report scores in patients with osteoarthritis indicate generally similar disease burden to patients with rheumatoid arthritis. Clin Exp Rheumatol. 2017 Sep-Oct; 35 Suppl 107(5):88-93.
    View in: PubMed
    Score: 0.034
  17. A RheuMetric physician checklist to quantitate levels of inflammation, damage and distress on 0-10 visual analogue scales. Clin Exp Rheumatol. 2017 Sep-Oct; 35 Suppl 107(5):21-25.
    View in: PubMed
    Score: 0.034
  18. Limited Value of the Multi-Biomarker Disease Activity Assay Compared to the Routine Assessment of Patient Index Data 3 (RAPID3) Score in the Prognosis of Important Clinical Outcomes in Rheumatoid Arthritis: Comment on the Article by Fleischmann et al and Accompanying Editorial by Davis. Arthritis Rheumatol. 2017 04; 69(4):866-867.
    View in: PubMed
    Score: 0.032
  19. Electronic multidimensional health assessment questionnaire (eMDHAQ): past, present and future of a proposed single data management system for clinical care, research, quality improvement, and monitoring of long-term outcomes. Clin Exp Rheumatol. 2016 Sep-Oct; 34(5 Suppl 101):S17-S33.
    View in: PubMed
    Score: 0.031
  20. Electronic eRAPID3 (Routine Assessment of Patient Index Data): opportunities and complexities. Clin Exp Rheumatol. 2016 Sep-Oct; 34(5 Suppl 101):S49-S53.
    View in: PubMed
    Score: 0.031
  21. Information technology in rheumatology. Clin Exp Rheumatol. 2016 Sep-Oct; 34(5 Suppl 101):1.
    View in: PubMed
    Score: 0.031
  22. Pragmatic assessment of exercise in routine care using an MDHAQ: associations with changes in RAPID3 and other clinical variables. Arthritis Res Ther. 2016 09 06; 18:199.
    View in: PubMed
    Score: 0.031
  23. Assessment of fatigue in routine care on a Multidimensional Health Assessment Questionnaire (MDHAQ): a cross-sectional study of associations with RAPID3 and other variables in different rheumatic diseases. Clin Exp Rheumatol. 2016 Sep-Oct; 34(5):901-909.
    View in: PubMed
    Score: 0.031
  24. Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other Core Data Set Measures, but Not by the Absence of Rheumatoid Factor, Anticitrullinated Protein Antibodies, or Radiographic Erosions. J Rheumatol. 2016 07; 43(7):1285-91.
    View in: PubMed
    Score: 0.030
  25. Limitations of clinical trials in chronic diseases: is the efficacy of methotrexate (MTX) underestimated in polyarticular psoriatic arthritis on the basis of limitations of clinical trials more than on limitations of MTX, as was seen in rheumatoid arthritis? Clin Exp Rheumatol. 2015 Sep-Oct; 33(5 Suppl 93):S82-93.
    View in: PubMed
    Score: 0.029
  26. Routine Assessment of Patient Index Data (RAPID3) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Scores Yield Similar Information in 85 Korean Patients With Ankylosing Spondylitis Seen in Usual Clinical Care. J Clin Rheumatol. 2015 Sep; 21(6):300-4.
    View in: PubMed
    Score: 0.029
  27. Premature Mortality: A Neglected Outcome in Rheumatic Diseases? Arthritis Care Res (Hoboken). 2015 Aug; 67(8):1043-6.
    View in: PubMed
    Score: 0.029
  28. RheuMetric A Physician Checklist to Record Patient Levels of Inflammation, Damage and Distress as Quantitative Data Rather than as Narrative Impressions. Bull Hosp Jt Dis (2013). 2015 Jul; 73(3):178-84.
    View in: PubMed
    Score: 0.029
  29. Rheumatoid arthritis: Predicting mortality in RA: the quest for useful information. Nat Rev Rheumatol. 2015 Sep; 11(9):507-9.
    View in: PubMed
    Score: 0.029
  30. Are patient self-report questionnaires as "scientific" as biomarkers in "treat-to-target" and prognosis in rheumatoid arthritis? Curr Pharm Des. 2015; 21(2):241-56.
    View in: PubMed
    Score: 0.028
  31. Circadian use of glucocorticoids in rheumatoid arthritis. Neuroimmunomodulation. 2015; 22(1-2):33-9.
    View in: PubMed
    Score: 0.027
  32. Clinical trials documenting the efficacy of low-dose glucocorticoids in rheumatoid arthritis. Neuroimmunomodulation. 2015; 22(1-2):46-50.
    View in: PubMed
    Score: 0.027
  33. The past versus the present, 1980-2004: reduction of mean initial low-dose, long-term glucocorticoid therapy in rheumatoid arthritis from 10.3 to 3.6 mg/day, concomitant with early methotrexate, with long-term effectiveness and safety of less than 5 mg/day. Neuroimmunomodulation. 2015; 22(1-2):89-103.
    View in: PubMed
    Score: 0.027
  34. Discordance of global estimates by patients and their physicians in usual care of many rheumatic diseases: association with 5 scores on a Multidimensional Health Assessment Questionnaire (MDHAQ) that are not found on the Health Assessment Questionnaire (HAQ). Arthritis Care Res (Hoboken). 2014 Jun; 66(6):934-42.
    View in: PubMed
    Score: 0.027
  35. Is a patient questionnaire without a joint examination as undesirable as a joint examination without a patient questionnaire? J Rheumatol. 2014 Apr; 41(4):619-21.
    View in: PubMed
    Score: 0.026
  36. Assessing remission in rheumatoid arthritis on the basis of patient reported outcomes--advantages of using RAPID3/MDHAQ in routine care. Bull Hosp Jt Dis (2013). 2014; 72(2):136-41.
    View in: PubMed
    Score: 0.026
  37. RHEUMDOC: a one-page RHEUMatology DOCtor form with four physician global estimates for overall status, inflammation, damage, and symptoms based on neither inflammation nor damage. Bull Hosp Jt Dis (2013). 2014; 72(2):142-7.
    View in: PubMed
    Score: 0.026
  38. Possible discontinuation of therapies in inflammatory rheumatic diseases - as with initiation of therapies, a shared decision between patient and rheumatologist. Clin Exp Rheumatol. 2013 Jul-Aug; 31(4 Suppl 78):S1-3.
    View in: PubMed
    Score: 0.025
  39. Documenting the value of care for rheumatoid arthritis, analogous to hypertension, diabetes, and hyperlipidemia: is control of individual patient self-report measures of global estimate and physical function more valuable than laboratory tests, radiographs, indices, or remission criteria? J Rheumatol. 2013 Sep; 40(9):1469-74.
    View in: PubMed
    Score: 0.025
  40. MDHAQ/RAPID3 to recognize improvement over 2 months in usual care of patients with osteoarthritis, systemic lupus erythematosus, spondyloarthropathy, and gout, as well as rheumatoid arthritis. J Clin Rheumatol. 2013 Jun; 19(4):169-74.
    View in: PubMed
    Score: 0.025
  41. Decline of mean initial prednisone dosage from 10.3 to 3.6 mg/day to treat rheumatoid arthritis between 1980 and 2004 in one clinical setting, with long-term effectiveness of dosages less than 5 mg/day. Arthritis Care Res (Hoboken). 2013 May; 65(5):729-36.
    View in: PubMed
    Score: 0.025
  42. Patient self-report RADAI (Rheumatoid Arthritis Disease Activity Index) joint counts on an MDHAQ (Multidimensional Health Assessment Questionnaire) in usual care of consecutive patients with rheumatic diseases other than rheumatoid arthritis. Arthritis Care Res (Hoboken). 2013 Feb; 65(2):288-93.
    View in: PubMed
    Score: 0.024
  43. Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort. J Rheumatol. 2013 Apr; 40(4):386-93.
    View in: PubMed
    Score: 0.024
  44. RAPID3, an index of only 3 patient self-report core data set measures, but not ESR, recognizes incomplete responses to methotrexate in usual care of patients with rheumatoid arthritis. Bull Hosp Jt Dis (2013). 2013; 71(2):117-20.
    View in: PubMed
    Score: 0.024
  45. Update on methotrexate as the anchor drug for rheumatoid arthritis. Bull Hosp Jt Dis (2013). 2013; 71 Suppl 1:S9-19.
    View in: PubMed
    Score: 0.024
  46. Efficacy and safety of methotrexate in combination with other non-biologic disease-modifying antirheumatic drugs (DMARDs) in treatment of rheumatoid arthritis. Bull Hosp Jt Dis (2013). 2013; 71 Suppl 1:S20-8.
    View in: PubMed
    Score: 0.024
  47. Evidence that the strategy is more important than the agent to treat rheumatoid arthritis. Data from clinical trials of combinations of non-biologic DMARDs, with protocol-driven intensification of therapy for tight control or treat-to-target. Bull Hosp Jt Dis (2013). 2013; 71 Suppl 1:S33-40.
    View in: PubMed
    Score: 0.024
  48. Treat-to-target: not as simple as it appears. Clin Exp Rheumatol. 2012 Jul-Aug; 30(4 Suppl 73):S10-20.
    View in: PubMed
    Score: 0.024
  49. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis. Ann Intern Med. 2012 Aug 21; 157(4):299; author reply 300.
    View in: PubMed
    Score: 0.024
  50. Importance of patient history and physical examination in rheumatoid arthritis compared to other chronic diseases: results of a physician survey. Arthritis Care Res (Hoboken). 2012 Aug; 64(8):1250-5.
    View in: PubMed
    Score: 0.023
  51. An evidence-based medical visit for patients with rheumatoid arthritis based on standard, quantitative scientific data from a patient MDHAQ and physician report. Bull NYU Hosp Jt Dis. 2012; 70(2):73-94.
    View in: PubMed
    Score: 0.023
  52. MDHAQ/RAPID3 can provide a roadmap or agenda for all rheumatology visits when the entire MDHAQ is completed at all patient visits and reviewed by the doctor before the encounter. Bull NYU Hosp Jt Dis. 2012; 70(3):177-86.
    View in: PubMed
    Score: 0.023
  53. Effective initial and long-term prednisone in doses of less than 5 mg/day to treat rheumatoid arthritis--documentation using a patient self-report Multidimensional Health Assessment Questionnaire (MDHAQ). Bull NYU Hosp Jt Dis. 2012; 70 Suppl 1:14-20.
    View in: PubMed
    Score: 0.023
  54. Pragmatic and scientific advantages of MDHAQ/ RAPID3 completion by all patients at all visits in routine clinical care. Bull NYU Hosp Jt Dis. 2012; 70 Suppl 1:30-6.
    View in: PubMed
    Score: 0.023
  55. Proposed severity and response criteria for Routine Assessment of Patient Index Data (RAPID3): results for categories of disease activity and response criteria in abatacept clinical trials. J Rheumatol. 2011 Dec; 38(12):2565-71.
    View in: PubMed
    Score: 0.022
  56. RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: Similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damage) clinical trial of certolizumab pegol. Arthritis Care Res (Hoboken). 2011 Aug; 63(8):1142-9.
    View in: PubMed
    Score: 0.022
  57. Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: a patient Multidimensional Health Assessment Questionnaire and physician estimate of noninflammatory symptoms. J Rheumatol. 2011 Jul; 38(7):1309-16.
    View in: PubMed
    Score: 0.021
  58. Differences in treat-to-target in patients with rheumatoid arthritis versus hypertension and diabetes--consequences for clinical care. Bull NYU Hosp Jt Dis. 2011; 69(2):104-10.
    View in: PubMed
    Score: 0.021
  59. MDHAQ/RAPID3 scores: quantitative patient history data in a standardized "scientific" format for optimal assessment of patient status and quality of care in rheumatic diseases. Bull NYU Hosp Jt Dis. 2011; 69(3):201-14.
    View in: PubMed
    Score: 0.021
  60. In the clinic. Rheumatoid arthritis. Ann Intern Med. 2010 Jul 06; 153(1):ITC1-1-ITC1-15; quiz ITC1-16.
    View in: PubMed
    Score: 0.020
  61. Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis. Rheumatology (Oxford). 2010 Sep; 49(9):1795-6; author reply 1796-7.
    View in: PubMed
    Score: 0.020
  62. RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds. Arthritis Care Res (Hoboken). 2010 Feb; 62(2):181-9.
    View in: PubMed
    Score: 0.020
  63. Are patient questionnaire scores as "scientific" as laboratory tests for rheumatology clinical care? Bull NYU Hosp Jt Dis. 2010; 68(2):130-9.
    View in: PubMed
    Score: 0.020
  64. Beyond RAPID3 - practical use of the MDHAQ to improve doctor-patient communication. Bull NYU Hosp Jt Dis. 2010; 68(3):223-31.
    View in: PubMed
    Score: 0.020
  65. Complexities in assessment of rheumatoid arthritis: absence of a single gold standard measure. Rheum Dis Clin North Am. 2009 Nov; 35(4):687-97, v.
    View in: PubMed
    Score: 0.019
  66. A biopsychosocial model to complement a biomedical model: patient questionnaire data and socioeconomic status usually are more significant than laboratory tests and imaging studies in prognosis of rheumatoid arthritis. Rheum Dis Clin North Am. 2009 Nov; 35(4):699-712, v.
    View in: PubMed
    Score: 0.019
  67. Joint counts to assess rheumatoid arthritis for clinical research and usual clinical care: advantages and limitations. Rheum Dis Clin North Am. 2009 Nov; 35(4):713-22, v-vi.
    View in: PubMed
    Score: 0.019
  68. Radiographic measures to assess patients with rheumatoid arthritis: advantages and limitations. Rheum Dis Clin North Am. 2009 Nov; 35(4):723-9, vi.
    View in: PubMed
    Score: 0.019
  69. Laboratory tests to assess patients with rheumatoid arthritis: advantages and limitations. Rheum Dis Clin North Am. 2009 Nov; 35(4):731-4, vi-vii.
    View in: PubMed
    Score: 0.019
  70. Patient questionnaires in rheumatoid arthritis: advantages and limitations as a quantitative, standardized scientific medical history. Rheum Dis Clin North Am. 2009 Nov; 35(4):735-43, vii.
    View in: PubMed
    Score: 0.019
  71. RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care. Rheum Dis Clin North Am. 2009 Nov; 35(4):773-8, viii.
    View in: PubMed
    Score: 0.019
  72. Complex measures and indices for clinical research compared with simple patient questionnaires to assess function, pain, and global estimates as rheumatology "vital signs" for usual clinical care. Rheum Dis Clin North Am. 2009 Nov; 35(4):779-86, ix.
    View in: PubMed
    Score: 0.019
  73. The HAQ compared with the MDHAQ: "keep it simple, stupid" (KISS), with feasibility and clinical value as primary criteria for patient questionnaires in usual clinical care. Rheum Dis Clin North Am. 2009 Nov; 35(4):787-98, ix.
    View in: PubMed
    Score: 0.019
  74. How to collect an MDHAQ to provide rheumatology vital signs (function, pain, global status, and RAPID3 scores) in the infrastructure of rheumatology care, including some misconceptions regarding the MDHAQ. Rheum Dis Clin North Am. 2009 Nov; 35(4):799-812, x.
    View in: PubMed
    Score: 0.019
  75. Quantitative recording of physician clinical estimates, beyond a global estimate and formal joint count, in usual care: applying the scientific method, using a simple one-page worksheet. Rheum Dis Clin North Am. 2009 Nov; 35(4):813-7, x.
    View in: PubMed
    Score: 0.019
  76. A multi-dimensional health assessment questionnaire (MDHAQ) and routine assessment of patient index data (RAPID3) scores are informative in patients with all rheumatic diseases. Rheum Dis Clin North Am. 2009 Nov; 35(4):819-27, x.
    View in: PubMed
    Score: 0.019
  77. Flowsheets that include MDHAQ physical function, pain, global, and RAPID3 scores, laboratory tests, and medications to monitor patients with all rheumatic diseases: an electronic database for an electronic medical record. Rheum Dis Clin North Am. 2009 Nov; 35(4):829-42, x-xi.
    View in: PubMed
    Score: 0.019
  78. A Standard Protocol to Evaluate Rheumatoid Arthritis (SPERA) for efficient capture of essential data from a patient and a health professional in a uniform "scientific" format. Rheum Dis Clin North Am. 2009 Nov; 35(4):843-50, xi.
    View in: PubMed
    Score: 0.019
  79. Quality control of a medical history: improving accuracy with patient participation, supported by a four-page version of the multidimensional health assessment questionnaire (MDHAQ). Rheum Dis Clin North Am. 2009 Nov; 35(4):851-60, xi.
    View in: PubMed
    Score: 0.019
  80. Criterion contamination of depression scales in patients with rheumatoid arthritis: the need for interpretation of patient questionnaires (as all clinical measures) in the context of all information about the patient. Rheum Dis Clin North Am. 2009 Nov; 35(4):861-4, xi-xii.
    View in: PubMed
    Score: 0.019
  81. Clues on the MDHAQ to identify patients with fibromyalgia and similar chronic pain conditions. Rheum Dis Clin North Am. 2009 Nov; 35(4):865-9, xii.
    View in: PubMed
    Score: 0.019
  82. Management of associated rheumatoid arthritis and fibromyalgia. J Rheumatol. 2009 Sep; 36(9):2123-4; discussion 2124-5.
    View in: PubMed
    Score: 0.019
  83. Pain and radiographic damage in osteoarthritis. BMJ. 2009 Aug 21; 339:b2802.
    View in: PubMed
    Score: 0.019
  84. Rheumatoid arthritis: strategy more important than agent. Lancet. 2009 Aug 08; 374(9688):430-2.
    View in: PubMed
    Score: 0.019
  85. Is a self-report RAPID3 score a reasonable alternative to a DAS28 in usual clinical care? J Clin Rheumatol. 2009 Aug; 15(5):215-7.
    View in: PubMed
    Score: 0.019
  86. Quantitative clinical rheumatology: why is a test for anti-CCP antibodies included in most routine care for rheumatoid arthritis while a HAQ/MDHAQ remains largely a research tool? J Rheumatol. 2009 Aug; 36(8):1563-4.
    View in: PubMed
    Score: 0.019
  87. Declines in erythrocyte sedimentation rates in patients with rheumatoid arthritis over the second half of the 20th century. J Rheumatol. 2009 Aug; 36(8):1596-9.
    View in: PubMed
    Score: 0.019
  88. Quantitative clinical rheumatology: "keep it simple, stupid": MDHAQ function, pain, global, and RAPID3 quantitative scores to improve and document the quality of rheumatologic care. J Rheumatol. 2009 Jun; 36(6):1099-100.
    View in: PubMed
    Score: 0.019
  89. Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States. J Rheumatol. 2009 Jul; 36(7):1387-90.
    View in: PubMed
    Score: 0.019
  90. RAPID3-an index of physical function, pain, and global status as "vital signs" to improve care for people with chronic rheumatic diseases. Bull NYU Hosp Jt Dis. 2009; 67(2):211-25.
    View in: PubMed
    Score: 0.018
  91. Can RAPID3, an index without formal joint counts or laboratory tests, serve to guide rheumatologists in tight control of rheumatoid arthritis in usual clinical care? Bull NYU Hosp Jt Dis. 2009; 67(3):254-66.
    View in: PubMed
    Score: 0.018
  92. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories. J Rheumatol. 2008 Nov; 35(11):2136-47.
    View in: PubMed
    Score: 0.018
  93. Hotel-based medicine. J Rheumatol. 2008 Aug; 35(8):1487-8.
    View in: PubMed
    Score: 0.018
  94. Quantitative clinical assessment in busy rheumatology settings: the value of short patient questionnaires. J Rheumatol. 2008 Jul; 35(7):1235-7.
    View in: PubMed
    Score: 0.018
  95. Visual analog scales in formats other than a 10 centimeter horizontal line to assess pain and other clinical data. J Rheumatol. 2008 Aug; 35(8):1550-8.
    View in: PubMed
    Score: 0.018
  96. Are excellent systematic reviews of clinical trials useful for patient care? Nat Clin Pract Rheumatol. 2008 Jun; 4(6):294-5.
    View in: PubMed
    Score: 0.018
  97. Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs. Mod Rheumatol. 2008; 18(3):228-39.
    View in: PubMed
    Score: 0.017
  98. Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores. J Rheumatol. 2008 Apr; 35(4):603-9.
    View in: PubMed
    Score: 0.017
  99. Pain, function, and RAPID scores: vital signs in chronic diseases, analogous to pulse and temperature in acute diseases and blood pressure and cholesterol in long-term health. Bull NYU Hosp Jt Dis. 2008; 66(2):155-65.
    View in: PubMed
    Score: 0.017
  100. Limitations of a quantitative swollen and tender joint count to assess and monitor patients with rheumatoid arthritis. Bull NYU Hosp Jt Dis. 2008; 66(3):216-23.
    View in: PubMed
    Score: 0.017
  101. Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials. J Rheumatol. 2008 Feb; 35(2):201-5.
    View in: PubMed
    Score: 0.017
  102. Quantitative measures of rheumatic diseases for clinical research versus standard clinical care: differences, advantages and limitations. Best Pract Res Clin Rheumatol. 2007 Aug; 21(4):601-28.
    View in: PubMed
    Score: 0.017
  103. A three-page Standard Protocol to Evaluate Rheumatoid Arthritis (SPERA) for efficient capture of essential data from patients and health professionals in standard clinical care and clinical research. Best Pract Res Clin Rheumatol. 2007 Aug; 21(4):677-85.
    View in: PubMed
    Score: 0.017
  104. Can a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores be informative in patients with all rheumatic diseases? Best Pract Res Clin Rheumatol. 2007 Aug; 21(4):733-53.
    View in: PubMed
    Score: 0.017
  105. A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10-20 seconds for use in standard clinical care, without rulers, calculators, websites or computers. Best Pract Res Clin Rheumatol. 2007 Aug; 21(4):755-87.
    View in: PubMed
    Score: 0.017
  106. A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative routine assessment of patient index data (RAPID) scores on a multidimensional health assessment questionnaire (MDHAQ). Best Pract Res Clin Rheumatol. 2007 Aug; 21(4):789-804.
    View in: PubMed
    Score: 0.017
  107. N-of-1 trial of low-dose methotrexate and/or prednisolone in lieu of anti-CCP, MRI, or ultrasound, as first option in suspected rheumatoid arthritis? J Rheumatol. 2007 Feb; 34(2):250-2.
    View in: PubMed
    Score: 0.016
  108. Shouldn't standard rheumatology clinical care be evidence-based rather than eminence-based, eloquence-based, or elegance-based? J Rheumatol. 2007 Jan; 34(1):1-4.
    View in: PubMed
    Score: 0.016
  109. A multidimensional health assessment questionnaire (MDHAQ) for all patients with rheumatic diseases to complete at all visits in standard clinical care. Bull NYU Hosp Jt Dis. 2007; 65(2):150-60.
    View in: PubMed
    Score: 0.016
  110. Patient questionnaires and formal education as more significant prognostic markers than radiographs or laboratory tests for rheumatoid arthritis mortality--limitations of a biomedical model to predict long-term outcomes. Bull NYU Hosp Jt Dis. 2007; 65 Suppl 1:S29-36.
    View in: PubMed
    Score: 0.016
  111. Improving survival in inflammatory rheumatic diseases: a neglected goal? Curr Rheumatol Rep. 2006 Dec; 8(6):401-3.
    View in: PubMed
    Score: 0.016
  112. Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trials. J Rheumatol. 2006 Dec; 33(12):2372-5.
    View in: PubMed
    Score: 0.016
  113. Quantitative measures to assess patients with rheumatic diseases: 2006 update. Rheum Dis Clin North Am. 2006 Dec; 32 Suppl 1:29-36.
    View in: PubMed
    Score: 0.016
  114. An index of patient reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis. J Rheumatol. 2006 Nov; 33(11):2146-52.
    View in: PubMed
    Score: 0.016
  115. Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population. Arthritis Rheum. 2006 Oct; 54(10):3113-8.
    View in: PubMed
    Score: 0.016
  116. The DAS is the most specific measure, but a patient questionnaire is the most informative measure to assess rheumatoid arthritis. J Rheumatol. 2006 May; 33(5):834-7.
    View in: PubMed
    Score: 0.015
  117. Saving time and improving care with a multidimensional health assessment questionnaire: 10 practical considerations. J Rheumatol. 2006 Mar; 33(3):448-54.
    View in: PubMed
    Score: 0.015
  118. Evidence-based practice and practice-based evidence. Nat Clin Pract Rheumatol. 2006 Mar; 2(3):114-5.
    View in: PubMed
    Score: 0.015
  119. Advantages and limitations of quantitative measures to assess rheumatoid arthritis: joint counts, radiographs, laboratory tests, and patient questionnaires. Bull NYU Hosp Jt Dis. 2006; 64(1-2):32-9.
    View in: PubMed
    Score: 0.015
  120. Radiographic benefit without clinical improvement in infliximab-treated patients with rheumatoid arthritis: comment on the article by Smolen et al. Arthritis Rheum. 2005 Dec; 52(12):4044-5; author reply 4045-7.
    View in: PubMed
    Score: 0.015
  121. A composite disease activity scale for clinical practice, observational studies, and clinical trials: the patient activity scale (PAS/PAS-II). J Rheumatol. 2005 Dec; 32(12):2410-5.
    View in: PubMed
    Score: 0.015
  122. Further development of a physical function scale on a MDHAQ [corrected] for standard care of patients with rheumatic diseases. J Rheumatol. 2005 Aug; 32(8):1432-9.
    View in: PubMed
    Score: 0.014
  123. Preliminary evaluation of a visual analog function scale for use in rheumatoid arthritis. J Rheumatol. 2005 Jul; 32(7):1261-6.
    View in: PubMed
    Score: 0.014
  124. Patient questionnaires for clinical research and improved standard patient care: is it better to have 80% of the information in 100% of patients or 100% of the information in 5% of patients? J Rheumatol. 2005 Apr; 32(4):575-7.
    View in: PubMed
    Score: 0.014
  125. Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria. Arthritis Rheum. 2005 Apr; 52(4):1031-6.
    View in: PubMed
    Score: 0.014
  126. Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis Rheum. 2005 Apr; 52(4):1009-19.
    View in: PubMed
    Score: 0.014
  127. Patient preference in a crossover clinical trial of patients with osteoarthritis of the knee or hip: face validity of self-report questionnaire ratings. J Rheumatol. 2005 Mar; 32(3):533-9.
    View in: PubMed
    Score: 0.014
  128. Clinical trials in rheumatic diseases: designs and limitations. Rheum Dis Clin North Am. 2004 Nov; 30(4):701-24, v-vi.
    View in: PubMed
    Score: 0.014
  129. Quantitative measures and indices to assess rheumatoid arthritis in clinical trials and clinical care. Rheum Dis Clin North Am. 2004 Nov; 30(4):725-51, vi.
    View in: PubMed
    Score: 0.014
  130. Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaire. Arthritis Rheum. 2004 Oct; 50(10):3296-305.
    View in: PubMed
    Score: 0.014
  131. Making an impact on mortality in rheumatoid arthritis: targeting cardiovascular comorbidity. Arthritis Rheum. 2004 Jun; 50(6):1734-9.
    View in: PubMed
    Score: 0.013
  132. Add-on or step-up trials in rheumatoid arthritis: comment on the article by Boers. Arthritis Rheum. 2004 Apr; 50(4):1351; author reply 1351-2.
    View in: PubMed
    Score: 0.013
  133. Patient questionnaires and formal education level as prospective predictors of mortality over 10 years in 97% of 1416 patients with rheumatoid arthritis from 15 United States private practices. J Rheumatol. 2004 Feb; 31(2):229-34.
    View in: PubMed
    Score: 0.013
  134. Quantitative measures for assessing rheumatoid arthritis in clinical trials and clinical care. Best Pract Res Clin Rheumatol. 2003 Oct; 17(5):753-81.
    View in: PubMed
    Score: 0.013
  135. Guidelines for monitoring of methotrexate therapy: "evidence-based medicine" outside of clinical trials. Arthritis Rheum. 2003 Oct; 48(10):2706-9.
    View in: PubMed
    Score: 0.013
  136. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission. J Rheumatol. 2003 Jun; 30(6):1138-46.
    View in: PubMed
    Score: 0.012
  137. Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha agents in rheumatoid arthritis. Arthritis Rheum. 2003 Feb; 48(2):313-8.
    View in: PubMed
    Score: 0.012
  138. Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients. J Rheumatol. 2002 Dec; 29(12):2521-4.
    View in: PubMed
    Score: 0.012
  139. Satisfaction With a Virtual Learning Collaborative Aimed at Implementing Treat-to-Target in Rheumatoid Arthritis. J Clin Rheumatol. 2022 Aug 01; 28(5):265-269.
    View in: PubMed
    Score: 0.012
  140. Implementing a Treat-to-Target Approach for Rheumatoid Arthritis During the COVID-19 Pandemic: Results of a Virtual Learning Collaborative Program. Arthritis Care Res (Hoboken). 2022 04; 74(4):572-578.
    View in: PubMed
    Score: 0.011
  141. Are long-term very low doses of prednisone for patients with rheumatoid arthritis as helpful as high doses are harmful?. Ann Intern Med. 2002 Jan 01; 136(1):76-8.
    View in: PubMed
    Score: 0.011
  142. Limitations of randomized clinical trials in chronic diseases: explanations and recommendations. Adv Mind Body Med. 2002; 18(2):14-21.
    View in: PubMed
    Score: 0.011
  143. Functional Status Measures and Indices in Rheumatoid Arthritis: Comment on the Articles by Barber et al and England et al. Arthritis Care Res (Hoboken). 2020 08; 72(8):1185-1186.
    View in: PubMed
    Score: 0.010
  144. Analysis of the discordance between radiographic changes and knee pain in osteoarthritis of the knee. J Rheumatol. 2000 Jun; 27(6):1513-7.
    View in: PubMed
    Score: 0.010
  145. Value of the Routine Assessment of Patient Index Data 3 in Patients With Psoriatic Arthritis: Results From a Tight-Control Clinical Trial and an Observational Cohort. Arthritis Care Res (Hoboken). 2018 08; 70(8):1198-1205.
    View in: PubMed
    Score: 0.009
  146. Implementation of Treat-to-Target in Rheumatoid Arthritis Through a Learning Collaborative: Results of a Randomized Controlled Trial. Arthritis Rheumatol. 2017 07; 69(7):1374-1380.
    View in: PubMed
    Score: 0.008
  147. Discordance of Global Assessments by Patient and Physician Is Higher in Female than in Male Patients Regardless of the Physician's Sex: Data on Patients with Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis from the DANBIO Registry. J Rheumatol. 2015 Oct; 42(10):1781-5.
    View in: PubMed
    Score: 0.007
  148. GUEPARD treat-to-target strategy is significantly more efficacious than ESPOIR routine care in early rheumatoid arthritis according to patient-reported outcomes and physician global estimate. Rheumatology (Oxford). 2013 Oct; 52(10):1890-7.
    View in: PubMed
    Score: 0.006
  149. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis. 2011 Mar; 70(3):404-13.
    View in: PubMed
    Score: 0.005
  150. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum. 2011 Mar; 63(3):573-86.
    View in: PubMed
    Score: 0.005
  151. Screening for low literacy in a rheumatology setting: more than 10% of patients cannot read "cartilage," "diagnosis," "rheumatologist," or "symptom". J Clin Rheumatol. 2010 Dec; 16(8):359-64.
    View in: PubMed
    Score: 0.005
  152. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010 Sep; 69(9):1580-8.
    View in: PubMed
    Score: 0.005
  153. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010 Sep; 62(9):2569-81.
    View in: PubMed
    Score: 0.005
  154. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report. Arthritis Rheum. 2010 Sep; 62(9):2582-91.
    View in: PubMed
    Score: 0.005
  155. Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis. J Rheumatol. 2010 Aug 01; 37(8):1633-8.
    View in: PubMed
    Score: 0.005
  156. Assessing dyspnea and its impact on patients with connective tissue disease-related interstitial lung disease. Respir Med. 2010 Sep; 104(9):1350-5.
    View in: PubMed
    Score: 0.005
  157. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study. Arthritis Res Ther. 2010; 12(2):R42.
    View in: PubMed
    Score: 0.005
  158. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum. 2009 Nov 15; 61(11):1580-5.
    View in: PubMed
    Score: 0.005
  159. Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum. 2009 Jul; 60(7):1906-14.
    View in: PubMed
    Score: 0.005
  160. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther. 2009; 11(1):R7.
    View in: PubMed
    Score: 0.005
  161. Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries. Arthritis Rheum. 2008 Sep; 58(9):2642-51.
    View in: PubMed
    Score: 0.004
  162. Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis. Arthritis Rheum. 2008 Sep; 58(9):2662-9.
    View in: PubMed
    Score: 0.004
  163. Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum. 2008 Jul; 58(7):2105-12.
    View in: PubMed
    Score: 0.004
  164. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther. 2008; 10(2):R30.
    View in: PubMed
    Score: 0.004
  165. Physical inactivity in patients with rheumatoid arthritis: data from twenty-one countries in a cross-sectional, international study. Arthritis Rheum. 2008 Jan 15; 59(1):42-50.
    View in: PubMed
    Score: 0.004
  166. Increased augmentation index in rheumatoid arthritis and its relationship to coronary artery atherosclerosis. J Rheumatol. 2007 Dec; 34(12):2388-94.
    View in: PubMed
    Score: 0.004
  167. Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis. Atherosclerosis. 2007 Dec; 195(2):e135-41.
    View in: PubMed
    Score: 0.004
  168. QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis. 2007 Nov; 66(11):1491-6.
    View in: PubMed
    Score: 0.004
  169. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis. 2008 Feb; 196(2):756-63.
    View in: PubMed
    Score: 0.004
  170. Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther. 2006; 8(6):R186.
    View in: PubMed
    Score: 0.004
  171. The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes. Arthritis Rheum. 2005 Dec; 52(12):3873-9.
    View in: PubMed
    Score: 0.004
  172. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum. 2005 Oct; 52(10):3045-53.
    View in: PubMed
    Score: 0.004
  173. Morning stiffness in patients with early rheumatoid arthritis is associated more strongly with functional disability than with joint swelling and erythrocyte sedimentation rate. J Rheumatol. 2004 Sep; 31(9):1723-6.
    View in: PubMed
    Score: 0.003
  174. The assessment of rheumatoid arthritis and the acceptability of self-report questionnaires in clinical practice. Arthritis Rheum. 2003 Feb 15; 49(1):59-63.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.